Legend Biotech Corp Adjustments For Finance Costs
Legend Biotech Corp (LEGN) reported Adjustments For Finance Costs of $21.40 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-10.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:AdjustmentsForFinanceCosts · last filed 2026-03-10
- Legend Biotech Corp adjustments for finance costs for the quarter ending 2025-12-31 was $5.48M, a 6.70% increase year-over-year.
- Legend Biotech Corp adjustments for finance costs for the quarter ending 2025-09-30 was $5.64M, a 2.40% increase year-over-year.
- Legend Biotech Corp adjustments for finance costs for the quarter ending 2025-06-30 was $5.22M, a 4.78% decline year-over-year.
- Legend Biotech Corp adjustments for finance costs for the quarter ending 2025-03-31 was $5.06M, a 7.56% decline year-over-year.
| Period end | Adjustments For Finance Costs 3 month | Adjustments For Finance Costs 6 month | Adjustments For Finance Costs 9 month | Adjustments For Finance Costs 12 month | Adjustments For Finance Costs 12 month as first filed |
|---|---|---|---|---|---|
| 2025-12-31 | $5.48M derived: 20-F 12 month − 6-K 9 month · filed 2026-03-10 | $11.12M derived: sum of 2 quarters · filed 2026-03-10 | $16.34M derived: sum of 3 quarters · filed 2026-03-10 | $21.40M 20-F · filed 2026-03-10 | |
| 2025-09-30 | $5.64M derived: 6-K 9 month − 6-K 6 month · filed 2025-11-12 | $10.86M derived: sum of 2 quarters · filed 2025-11-12 | $15.92M 6-K · filed 2025-11-12 | $21.06M derived: sum of 4 quarters · filed 2026-03-10 | |
| 2025-06-30 | $5.22M derived: 6-K 6 month − 6-K 3 month · filed 2025-08-11 | $10.28M 6-K · filed 2025-08-11 | $15.42M derived: sum of 3 quarters · filed 2026-03-10 | $20.92M derived: sum of 4 quarters · filed 2026-03-10 | |
| 2025-03-31 | $5.06M 6-K · filed 2025-05-13 | $10.20M derived: sum of 2 quarters · filed 2026-03-10 | $15.70M derived: sum of 3 quarters · filed 2026-03-10 | $21.19M derived: sum of 4 quarters · filed 2026-03-10 | |
| 2024-12-31 | $5.14M derived: 20-F 12 month − 6-K 9 month · filed 2026-03-10 | $10.64M derived: sum of 2 quarters · filed 2026-03-10 | $16.13M derived: sum of 3 quarters · filed 2026-03-10 | $21.60M 20-F · filed 2026-03-10 | $21.61M 20-F · filed 2025-03-11 |
| 2024-09-30 | $5.50M derived: 6-K 9 month − 6-K 6 month · filed 2025-11-12 | $10.99M derived: sum of 2 quarters · filed 2025-11-12 | $16.46M 6-K · filed 2025-11-12 | $22.29M derived: sum of 4 quarters · filed 2026-03-10 | |
| 2024-06-30 | $5.48M derived: 6-K 6 month − 6-K 3 month · filed 2025-08-11 | $10.96M 6-K · filed 2025-08-11 | $16.79M derived: sum of 3 quarters · filed 2026-03-10 | $22.46M derived: sum of 4 quarters · filed 2026-03-10 | |
| 2024-03-31 | $5.47M 6-K · filed 2025-05-13 | $11.30M derived: sum of 2 quarters · filed 2026-03-10 | $16.98M derived: sum of 3 quarters · filed 2026-03-10 | $22.16M derived: sum of 4 quarters · filed 2026-03-10 | |
| 2023-12-31 | $5.83M derived: 20-F 12 month − 6-K 9 month · filed 2026-03-10 | $11.50M derived: sum of 2 quarters · filed 2026-03-10 | $16.69M derived: sum of 3 quarters · filed 2026-03-10 | $21.80M 20-F · filed 2026-03-10 | $21.79M 20-F · filed 2024-03-19 |
| 2023-09-30 | $5.68M derived: 6-K 9 month − 6-K 6 month · filed 2024-11-12 | $10.86M derived: sum of 2 quarters · filed 2024-11-12 | $15.97M 6-K · filed 2024-11-12 | $20.84M derived: sum of 4 quarters · filed 2025-03-11 | |
| 2023-06-30 | $5.18M derived: 6-K 6 month − 6-K 3 month · filed 2024-08-09 | $10.30M 6-K · filed 2024-08-09 | $15.16M derived: sum of 3 quarters · filed 2025-03-11 | $18.41M derived: sum of 4 quarters · filed 2025-03-11 | |
| 2023-03-31 | $5.11M 6-K · filed 2024-05-13 | $9.97M derived: sum of 2 quarters · filed 2025-03-11 | $13.22M derived: sum of 3 quarters · filed 2025-03-11 | ||
| 2022-12-31 | $4.86M derived: 20-F 12 month − 6-K 9 month · filed 2025-03-11 | $8.11M derived: sum of 2 quarters · filed 2025-03-11 | $10.80M 20-F · filed 2025-03-11 | ||
| 2022-09-30 | $3.25M derived: 6-K 9 month − 6-K 6 month · filed 2023-11-20 | $5.93M 6-K · filed 2023-11-20 | |||
| 2022-06-30 | $2.69M 6-K · filed 2023-08-15 | ||||
| 2021-12-31 | $900.00K 20-F · filed 2024-03-19 | ||||
| 2021-06-30 | $90.00K 6-K · filed 2021-08-23 | ||||
| 2020-12-31 | $4.21M 20-F · filed 2023-03-30 | ||||
| 2020-06-30 | $4.08M 6-K · filed 2021-08-23 | ||||
| 2019-12-31 | $223.00K 20-F/A · filed 2023-02-17 | ||||
| 2018-12-31 | $82.00K 20-F · filed 2021-04-02 |